GO:0046716 muscle cell cellular homeostasis: Maintenance Mechanisms, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0046716 (muscle cell cellular homeostasis) describes the cellular process that preserves a muscle cell in a stable functional or structural state, encompassing both skeletal and vascular smooth muscle cells.
Single-cell transcriptomic atlases of the human heart have revealed distinct muscle cell populations and their homeostatic gene programs, providing a reference for studying this process.
Vascular smooth muscle cell homeostasis is epigenetically controlled by chromatin-remodeling complexes such as BAF60c and by poly(ADP-ribose) polymerase 1, and its disruption contributes to aortic aneurysm and arterial disease.
Skeletal muscle homeostasis depends on microtubule networks that support myofiber architecture, vesicle trafficking, and organelle positioning.
Metabolic and redox signals, including PGC1-alpha-dependent myokine secretion and NAD+ balance, are integral to maintaining muscle cell stability.
CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal testing of genes implicated in muscle cell cellular homeostasis.

Description

Muscle cell cellular homeostasis (GO:0046716) is the biological process that preserves a muscle cell in a stable functional or structural state. This Gene Ontology term captures the cell-autonomous mechanisms that maintain the contractile apparatus, metabolic capacity, organelle organization, and stress-response pathways of muscle cells, including skeletal myofibers, cardiac muscle cells, and vascular smooth muscle cells. Because muscle cells are long-lived and mechanically active, their homeostatic programs must continuously balance protein turnover, ion handling, energy supply, and structural repair.

muscle cell cellular homeostasis At A Glance

GO ID GO:0046716
GO term muscle cell cellular homeostasis
Ontology biological_process
Synonym muscle fiber maintenance; muscle homeostasis
Definition The cellular homeostatic process that preserves a muscle cell in a stable functional or structural state.
Major function Maintains muscle cell structural integrity, contractile capacity, metabolic balance, and stress resilience.
Cell types involved Skeletal myofibers, cardiac muscle cells, vascular smooth muscle cells, and related muscle lineages.
Representative regulators BAF60c (SMARCD3), PARP1, PGC1-alpha (PPARGC1A), RYR1, and microtubule-associated proteins.
Disease relevance Aortic aneurysm, arterial disease, RYR1-related myopathies, and muscle metabolic dysfunction.

What Is GO:0046716?

GO:0046716 is defined as the cellular homeostatic process that preserves a muscle cell in a stable functional or structural state. In practice, this includes the regulated maintenance of sarcomeric and cytoskeletal architecture, mitochondrial and metabolic function, calcium and redox balance, and the ability to respond to injury or stress without losing the differentiated muscle cell phenotype. The term is synonymous with muscle fiber maintenance and muscle homeostasis.

Why Is muscle cell cellular homeostasis Important in Cell Biology?

Understanding muscle cell cellular homeostasis is essential because loss of this process underlies a broad spectrum of human disorders, from vascular smooth muscle-driven aortic aneurysm and arterial disease to skeletal muscle myopathies and metabolic dysfunction. Single-cell studies of the human heart have shown that muscle cell populations express distinct homeostatic gene programs, and perturbations in these programs can drive pathology. Consequently, genes controlling muscle cell homeostasis are attractive targets for mechanistic research and therapeutic development.
Maintains contractile and structural integrity of skeletal, cardiac, and vascular smooth muscle cells.
Prevents vascular smooth muscle cell phenotypic switching that contributes to aortic aneurysm and arterial disease.
Supports metabolic homeostasis through PGC1-alpha-dependent myokine signaling and NAD+ balance.
Requires intact microtubule networks for myofiber organization and organelle positioning.
Provides a framework for interpreting single-cell transcriptomic atlases of muscle tissues.
Links epigenetic regulation, including BAF60c and PARP1, to muscle cell stability.
Offers candidate targets for RYR1-related myopathies and other muscle disorders.
Enables CRISPR-based causal testing of homeostasis genes in disease models.

What Happens During muscle cell cellular homeostasis?

Maintenance of contractile and cytoskeletal architecture
In simple terms: Muscle cells constantly repair and organize their internal skeleton so they can keep contracting properly.
Muscle cell homeostasis requires the continuous organization of sarcomeric and cytoskeletal structures. Microtubules in skeletal muscle are essential for myofiber development and for maintaining the spatial arrangement of organelles and nuclei, and their disruption impairs muscle cell stability. Single-cell transcriptomic studies of the human heart have identified distinct muscle cell populations with specialized structural gene programs, underscoring the diversity of homeostatic architectures across muscle cell types.
Metabolic and mitochondrial balance
In simple terms: Muscle cells must manage their energy supply and mitochondrial health to stay functional.
Metabolic homeostasis is a core component of muscle cell stability. PGC1-alpha-dependent signaling drives the secretion of myokines such as irisin, which influences systemic energy balance and thermogenesis, linking muscle cell metabolic state to whole-body physiology. In RYR1-related myopathies, NAD+ dyshomeostasis has been identified as a feature of muscle cell dysfunction, indicating that redox and metabolic balance are critical for maintaining muscle cell homeostasis.
Epigenetic and transcriptional control
In simple terms: Muscle cells use epigenetic switches to keep the right genes on or off for stable function.
Chromatin-remodeling complexes control the transcriptional programs that maintain muscle cell identity. BAF60c (SMARCD3) prevents abdominal aortic aneurysm formation through epigenetic control of vascular smooth muscle cell homeostasis, demonstrating that epigenetic regulators are required for stable muscle cell states. Similarly, poly(ADP-ribose) polymerase 1 orchestrates vascular smooth muscle cell homeostasis in arterial disease, linking chromatin-associated processes to muscle cell stability.
Stress response and cell survival
In simple terms: Muscle cells have quality-control systems that help them survive stress and avoid damage.
Muscle cells must respond to mechanical, metabolic, and oxidative stress to remain stable. The maintenance of NAD+ levels and the regulation of calcium-handling proteins such as RYR1 are important for preventing stress-induced muscle cell dysfunction. Microtubule-dependent trafficking also supports the delivery of proteins and organelles needed for stress responses in skeletal muscle.
Cell-type-specific homeostatic programs
In simple terms: Different muscle cells use different sets of genes to stay healthy.
Single-cell and single-nucleus RNA sequencing of the adult human heart has revealed transcriptional and cellular diversity among muscle cell populations, including distinct homeostatic gene expression signatures. This heterogeneity means that the mechanisms preserving muscle cell homeostasis can differ between cardiac, skeletal, and vascular smooth muscle cells, and should be studied in a cell-type-specific manner.

Key Genes Involved in GO:0046716 muscle cell cellular homeostasis

The following genes and proteins have been experimentally implicated in muscle cell cellular homeostasis or in closely related muscle cell maintenance processes.
GeneMajor RoleResearch Relevance
SMARCD3 (BAF60c)Epigenetic control of vascular smooth muscle cell homeostasisPrevents abdominal aortic aneurysm formation; chromatin-remodeling target
PARP1Orchestrates vascular smooth muscle cell homeostasis in arterial diseaseLinks DNA-damage/ADP-ribosylation signaling to muscle cell stability
PPARGC1A (PGC1-alpha)Drives myokine secretion and metabolic homeostasisRegulates irisin and brown-fat-like thermogenesis
RYR1Calcium release channel required for muscle cell functionNAD+ dyshomeostasis in RYR1-related myopathies
MAPs (microtubule-associated proteins)Maintain microtubule networks in skeletal muscleSupport myofiber development and homeostasis
TUBB/TUBA (tubulins)Build microtubule cytoskeletonEssential for muscle cell structural maintenance
MYH7Sarcomeric myosin heavy chainCardiac muscle cell identity and contractile homeostasis
ACTC1Sarcomeric actinCardiac and skeletal muscle cell structural maintenance
TNNT2Sarcomeric troponinContractile apparatus homeostasis in cardiac muscle
NPPACardiac stress-responsive natriuretic peptideMarker of cardiac muscle cell state
MYL2Regulatory myosin light chainVentricular muscle cell homeostasis
GJA1 (Connexin 43)Gap junction coupling in muscle cellsIntercellular communication for tissue homeostasis
VIMIntermediate filament proteinCytoskeletal stability in muscle cells
DMDDystrophin, links cytoskeleton to membraneMuscle cell membrane stability (related literature)
DESDesmin intermediate filamentMaintains muscle cell structural integrity
SOD2Mitochondrial antioxidant enzymeProtects muscle cells from oxidative stress
PPARAFatty acid oxidation regulatorMetabolic homeostasis in muscle cells

How Is muscle cell cellular homeostasis Regulated?

Muscle cell cellular homeostasis is regulated at multiple levels. Epigenetic control by chromatin-remodeling complexes such as BAF60c maintains the transcriptional programs required for vascular smooth muscle cell stability, and its loss promotes aneurysm formation. PARP1 activity similarly orchestrates vascular smooth muscle cell homeostasis, linking ADP-ribosylation and DNA-damage responses to muscle cell state. Metabolic regulation through PGC1-alpha-dependent myokine secretion connects muscle cell energy status to systemic metabolism. In skeletal muscle, microtubule dynamics and associated proteins regulate organelle positioning and structural maintenance. NAD+ availability and calcium-handling proteins such as RYR1 further modulate muscle cell stress responses and survival.

muscle cell cellular homeostasis and Human Disease

GeneDisease / BiologyPotential Experimental Model
SMARCD3 (BAF60c)Abdominal aortic aneurysm; vascular smooth muscle cell homeostasisVSMC-specific knockout or overexpression in mouse aneurysm models
PARP1Arterial disease; vascular smooth muscle cell homeostasisPARP1 knockout or point-mutation in vascular smooth muscle cells
RYR1RYR1-related myopathies; NAD+ dyshomeostasisPatient-derived myotubes or RYR1 knock-in models
PPARGC1A (PGC1-alpha)Metabolic homeostasis; myokine secretionMuscle-specific overexpression or knockout models
Microtubule-associated proteinsSkeletal muscle development and homeostasisCRISPR knockout in myoblast differentiation systems
Vascular smooth muscle cell homeostasis and aortic disease
Disruption of vascular smooth muscle cell homeostasis is a key event in aortic aneurysm and arterial disease. BAF60c prevents abdominal aortic aneurysm formation through epigenetic control of vascular smooth muscle cell homeostasis, and loss of this regulation is associated with disease progression. PARP1 has also been shown to orchestrate vascular smooth muscle cell homeostasis in arterial disease, highlighting the importance of chromatin-associated and DNA-damage signaling pathways in maintaining vascular muscle cell stability.
RYR1-related myopathies and metabolic dyshomeostasis
RYR1-related myopathies are associated with NAD+ dyshomeostasis, indicating that metabolic and redox imbalance contributes to muscle cell dysfunction. This suggests that therapies aimed at restoring NAD+ balance or improving mitochondrial function may help preserve muscle cell homeostasis in these conditions.
Cardiac muscle cell diversity and disease modeling
Single-cell transcriptomic studies of the adult human heart have revealed distinct cardiac muscle cell populations and their homeostatic gene programs, providing a reference for understanding how perturbations in these programs may contribute to heart disease. These datasets are valuable for identifying cell-type-specific vulnerabilities and for designing targeted experiments.
Skeletal muscle structural homeostasis and myopathies
Microtubule networks are essential for skeletal muscle development and homeostasis, and their disruption can impair myofiber structure and function. Defects in cytoskeletal and sarcomeric maintenance pathways are therefore relevant to a range of skeletal muscle disorders.

From muscle cell cellular homeostasis-Related Genes to Experimental Models

Research QuestionSuitable Model
Is a candidate gene required for vascular smooth muscle cell homeostasis?CRISPR knockout in vascular smooth muscle cells followed by phenotypic assays
Does a specific point mutation in RYR1 alter muscle cell homeostasis?Point-mutation knock-in in muscle cell lines or patient-derived myotubes
Can overexpression of a metabolic regulator preserve muscle cell stability?Overexpression of PGC1-alpha or related genes in muscle cells
How does a chromatin regulator control muscle cell gene programs?Tagged knock-in of BAF60c or PARP1 for ChIP-seq and interaction studies
What is the role of microtubule networks in myofiber maintenance?Knockout or knockdown of microtubule-associated proteins in skeletal muscle cells
Which muscle cell populations express homeostatic genes?Single-cell RNA-seq of human heart or muscle tissue

How to Study the muscle cell cellular homeostasis Process

MethodWhat It MeasuresTypical Application
Single-cell RNA-seqCell-type-specific gene expression programsDefining muscle cell diversity and homeostatic signatures
CRISPR knockoutLoss-of-function effects on muscle cell homeostasisTesting requirement of candidate genes
Point-mutation knock-inEffect of specific disease-associated variantsModeling RYR1-related myopathies
OverexpressionGain-of-function effects on muscle cell stabilityTesting metabolic regulators such as PGC1-alpha
Immunofluorescence microscopyCytoskeletal and organelle organizationAssessing microtubule networks in skeletal muscle
NAD+ quantificationRedox and metabolic balanceEvaluating muscle cell dyshomeostasis
Chromatin immunoprecipitation (ChIP-seq)Epigenetic regulation of homeostatic genesStudying BAF60c and PARP1 function
Seahorse metabolic analysisMitochondrial respiration and glycolysisMeasuring metabolic homeostasis in muscle cells
Single-cell transcriptomics
Single-cell and single-nucleus RNA sequencing of human heart and muscle tissues has been used to define muscle cell populations and their homeostatic gene expression programs. These methods are essential for identifying cell-type-specific regulators of muscle cell cellular homeostasis and for comparing healthy and diseased states.
CRISPR-based functional genomics
CRISPR knockout, point-mutation, knock-in, and overexpression approaches allow causal testing of genes implicated in muscle cell homeostasis. For example, knockout of BAF60c or PARP1 in vascular smooth muscle cells can reveal their requirement for maintaining stable muscle cell states. Point mutations in RYR1 can be introduced to model myopathy-associated dysfunction.
Imaging and cytoskeletal analysis
Microscopy-based methods are used to assess muscle cell structure, organelle positioning, and microtubule organization. These approaches are particularly relevant for studying the role of microtubule networks in skeletal muscle development and homeostasis.
Metabolic and redox assays
Measurements of NAD+ levels, mitochondrial function, and oxidative stress are used to evaluate metabolic homeostasis in muscle cells. Such assays have been applied in RYR1-related myopathy models to demonstrate NAD+ dyshomeostasis and in studies of PGC1-alpha-dependent myokine secretion.

How CRISPR Can Be Used to Study GO:0046716 muscle cell cellular homeostasis

Knockout

CRISPR knockout is used to delete genes such as SMARCD3 (BAF60c) or PARP1 in vascular smooth muscle cells to test their requirement for muscle cell cellular homeostasis. Loss of BAF60c promotes abdominal aortic aneurysm formation, demonstrating a causal role in maintaining vascular smooth muscle cell stability. PARP1 knockout similarly reveals its role in orchestrating vascular smooth muscle cell homeostasis in arterial disease.

Point Mutation

Point-mutation knock-in via CRISPR is valuable for modeling disease-associated variants in genes such as RYR1, which is linked to RYR1-related myopathies and NAD+ dyshomeostasis. Introducing specific mutations allows researchers to dissect how single amino acid changes affect muscle cell calcium handling, metabolism, and survival.

Knock-in

Tagged knock-in of genes such as BAF60c or PARP1 enables chromatin immunoprecipitation, imaging, and interaction studies to define how these regulators control muscle cell homeostatic gene programs. Knock-in of reporter or affinity tags preserves endogenous regulation and provides physiologically relevant readouts.

Overexpression

CRISPR-based overexpression or cDNA overexpression of metabolic regulators such as PGC1-alpha can be used to test whether enhancing a specific pathway preserves or improves muscle cell homeostasis. Overexpression models are also useful for studying myokine secretion and its effects on systemic metabolism.

How EDITGENE Supports muscle cell cellular homeostasis Research

Researchers studying muscle cell cellular homeostasis-related genes often need to determine whether a candidate gene is causally involved in maintaining muscle cell stability or whether its perturbation drives disease. EDITGENE provides CRISPR-based cell model engineering and screening services to support these mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for muscle cell cellular homeostasis research.

Frequently Asked Questions About muscle cell cellular homeostasis

GO:0046716 is a Gene Ontology biological process term defined as the cellular homeostatic process that preserves a muscle cell in a stable functional or structural state. It covers mechanisms that maintain muscle cell architecture, metabolism, and stress resilience.
Genes experimentally implicated include SMARCD3 (BAF60c), PARP1, PPARGC1A (PGC1-alpha), RYR1, and microtubule-associated proteins, among others.
Vascular smooth muscle cell homeostasis is regulated by epigenetic factors such as BAF60c and by PARP1, which control transcriptional and chromatin-associated programs required for stable muscle cell states.
Defects have been linked to abdominal aortic aneurysm, arterial disease, RYR1-related myopathies, and skeletal muscle structural disorders.
Microtubules are required for skeletal muscle development and for maintaining myofiber structure, organelle positioning, and intracellular trafficking.
CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal testing of candidate genes in muscle cells, including SMARCD3, PARP1, and RYR1.
NAD+ dyshomeostasis refers to disrupted NAD+ balance observed in RYR1-related myopathies, indicating that metabolic and redox imbalance contributes to muscle cell dysfunction.
The term applies to muscle cells broadly, including skeletal myofibers, cardiac muscle cells, and vascular smooth muscle cells, as reflected in single-cell studies of the human heart and muscle.
Single-cell RNA-seq reveals distinct muscle cell populations and their homeostatic gene expression programs, enabling cell-type-specific analysis of muscle cell stability.
Models include CRISPR knockout and knock-in cell lines, patient-derived myotubes, overexpression systems, and single-cell transcriptomic profiling of muscle tissues.

Conclusion

GO:0046716 muscle cell cellular homeostasis defines the cell-autonomous mechanisms that keep muscle cells structurally and functionally stable. Research using single-cell transcriptomics, CRISPR-based perturbation, and metabolic assays has identified key regulators such as BAF60c, PARP1, PGC1-alpha, RYR1, and microtubule-associated proteins. These findings link muscle cell homeostasis to aortic aneurysm, arterial disease, and myopathies, making this process a rich area for mechanistic and therapeutic investigation.

References

  1. 1. Litviňuková M et al.. 2020. Cells of the adult human heart.. Nature 588(7838):466-472 PMID: 32971526
  2. 2. Zhao G et al.. 2022. BAF60c prevents abdominal aortic aneurysm formation through epigenetic control of vascular smooth muscle cell homeostasis.. J Clin Invest 132(21) PMID: 36066968
  3. 3. Boström P et al.. 2012. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis.. Nature 481(7382):463-8 PMID: 22237023
  4. 4. Tucker NR et al.. 2020. Transcriptional and Cellular Diversity of the Human Heart.. Circulation 142(5):466-482 PMID: 32403949
  5. 5. Lawal TA et al.. 2025. NAD(+) dyshomeostasis in RYR1-related myopathies.. Skelet Muscle 15(1):22 PMID: 40846977
  6. 7. Xu W et al.. 2025. Poly(ADP-ribose) polymerase 1 orchestrates vascular smooth muscle cell homeostasis in arterial disease.. Exp Mol Med 57(8):1686-1699 PMID: 40744995
  7. 8. Lucas L et al.. 2023. Insights into Cell-Specific Functions of Microtubules in Skeletal Muscle Development and Homeostasis.. Int J Mol Sci 24(3) PMID: 36769228
Contact Us
*
*
*
*
How did you hear about us: